ADCC News and Research

RSS
SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

SARS-CoV-2 infection induces polyfunctional antibodies that can destroy infected cells

SARS-CoV-2 infection induces polyfunctional antibodies that can destroy infected cells

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

New type of antibody marks infected cells, makes them visible to the immune system

New type of antibody marks infected cells, makes them visible to the immune system

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Antibody-Fc-mediated innate immunity shapes COVID-19 severity

Antibody-Fc-mediated innate immunity shapes COVID-19 severity

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Balanced B and T cell response required to control SARS-CoV-2

Balanced B and T cell response required to control SARS-CoV-2

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

New combination therapy can lead to durable responses in patients with multiple myeloma

New combination therapy can lead to durable responses in patients with multiple myeloma

New study shows response to HIV vaccine in 6 weeks

New study shows response to HIV vaccine in 6 weeks

New study shows response to HIV vaccine in 6 weeks

New study shows response to HIV vaccine in 6 weeks